Roles and challenges of a Swiss hospital pharmacy during the COVID-19 pandemic

Détails

Ressource 1Télécharger: FIP20_phel_covid.pdf (7440.62 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_D1B329727EF1
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Abstract (résumé de présentation): article court qui reprend les éléments essentiels présentés à l'occasion d'une conférence scientifique dans un poster ou lors d'une intervention orale.
Collection
Publications
Titre
Roles and challenges of a Swiss hospital pharmacy during the COVID-19 pandemic
Titre de la conférence
Pharmacy Education
Auteur⸱e⸱s
Schumacher L., Blatrie C., Krähenbühl S., Pasteur C., Blanc A.-L., Pellaton C., Rouiller F., Widmer N.
Organisation
International Pharmaceutical Federation (FIP) Virtual 2020
Adresse
September 4-25, 2020
Statut éditorial
Publié
Date de publication
2020
Peer-reviewed
Oui
Volume
20
Numéro
3
Pages
41
Langue
anglais
Résumé
Background: On March 16, 2020, because of the COVID-19 pandemic, the Swiss Federal Council declared an ‘extraordinary situation’ in terms of the Epidemics Act.
Purpose: To assess the roles of an inter-hospital pharmacy in the fight against SARS-CoV-2.
Method: All missions performed by our pharmacy were systematically collected and evaluated. They were also compared to its official duties.
Results: Specific missions, which have been mainly managed by the crisis unit and the four departments of the pharmacy (Pharmaceutical Logistics, Drug Manufacturing, Clinical Pharmacy and Nursing Homes Supply), were: 1) human resources continuity; 2) specific drug supply (for both hospitals and nursing homes; e.g. anaesthetics, sedatives, antiviral drugs, incl. for clinical trials); 3) clinical assistance (especially in the ICU of the main acute hospital); 4) individual drug manufacturing (e.g. hydroxychloroquine oral solution); 5) on-site pharmacies management; 6) own infrastructure securing (especially in term of hygiene); 7) hand disinfectant production; and 8) hygienic masks supply for healthcare professionals in the area. The two last missions were out of the traditional duties of our pharmacy and have been achieved with the support of staff from the Swiss civil protection. A particular challenge was the management of the shortage of various products and the identification of alternative therapeutic options.
Conclusion: Our pharmacy has faced various challenges during the acute pandemic situation. Some missions performed were even beyond our traditional ones. The disaster plan of our pharmacy has to be further developed, as well as the associated training of the staff, based on the lessons learned from this pandemic.
Création de la notice
12/11/2020 18:24
Dernière modification de la notice
19/01/2022 17:28
Données d'usage